Skip to content
Home/Companies/MedTech/Endocontrol

Endocontrol

MedTech·France·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns Endocontrol?

Endocontrol is a French MedTech company, currently owned by Seventure Partners since 2017.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
Spef Pre-IPO · 2007 · VC

Key facts

HQFrance
SectorMedTech

More Seventure Partners portfolio companies

From the same investor, across funds.

Clinical Microbiomics
Active
Launchmetrics
Active
Software
Idnow
Idnow
Active
CybersecurityGermany· 2026
Kainova Therapeutics
Kainova Therapeutics
Active
BiotechCanada· 2026
MaaT Pharma
MaaT Pharma
Active
BiotechFrance· 2026
Mediads
Mediads
Active
E-commerceFrance· 2026

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Endocontrol?

Endocontrol is currently owned by Seventure Partners, through Spef Pre-IPO, since 2017.

When did Seventure Partners acquire Endocontrol?

Seventure Partners acquired Endocontrol in 2017.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue